Big Pharma plays CMO as Pfizer signs on to produce Covid-19 drug remdesivir for Gilead – MedCity News
Gilead Sciences had said in its second-quarter earnings that it would partner with companies in North America, Europe and Asia to manufacture the antiviral drug, which received an emergency use authorization from the FDA in May.